These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22726077)

  • 1. Clinical trial design in haemophilia.
    Dimichele DM; Blanchette V; Berntorp E
    Haemophilia; 2012 Jul; 18 Suppl 4():18-23. PubMed ID: 22726077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune tolerance: critical issues of factor dose, purity and treatment complications.
    DiMichele DM
    Haemophilia; 2006 Dec; 12 Suppl 6():81-5; discussion 85-6. PubMed ID: 17123399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint WFH-ISTH session: issues in clinical trial design.
    Peyvandi F; Farrugia A; Iorio A; Key NS; Srivastava A
    Haemophilia; 2014 May; 20 Suppl 4():137-44. PubMed ID: 24762289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilia registries to complement clinical trial data: a pious hope or an urgent necessity?: Reflections on a possible way forward.
    Keipert C; van den Berg HM; Keller-Stanislawski B; Hilger A
    Haemophilia; 2016 Sep; 22(5):647-50. PubMed ID: 27397094
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
    Berntorp E; Shapiro AD; Waters J; Astermark J
    Haemophilia; 2014 Sep; 20(5):e362-4. PubMed ID: 25156443
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease.
    Rizza CR; Kernoff PB; Matthews JM; McLennan CR; Rainsford SG
    Thromb Haemost; 1977 Feb; 37(1):86-90. PubMed ID: 320712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current issues in prophylactic therapy for persons with hemophilia.
    Dunn AL; Abshire TC
    Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the treatment of bleeding disorders.
    Bergman GE
    Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium content in products used to treat haemophilia.
    Altisent C; Martorell M; de la Sierra A
    Haemophilia; 2016 Jul; 22(4):e324-7. PubMed ID: 27228069
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.
    Collins P; Chalmers E; Chowdary P; Keeling D; Mathias M; O'Donnell J; Pasi KJ; Rangarajan S; Thomas A
    Haemophilia; 2016 Jul; 22(4):487-98. PubMed ID: 27311929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for individualizing haemophilia care.
    Sørensen B; Auerswald G; Benson G; Elezović I; Felder M; Lambert T; Morfini M; Remor E; Salaj P; Santagostino E; Šalek SZ; Ljung R
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):849-57. PubMed ID: 25396764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
    Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
    Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of treatment logs by haemophilia patients.
    du Treil S; Rice J; Leissinger CA
    Haemophilia; 2010 May; 16(3):545-7. PubMed ID: 20050930
    [No Abstract]   [Full Text] [Related]  

  • 14. PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers.
    Ivens IA; Baumann A; McDonald TA; Humphries TJ; Michaels LA; Mathew P
    Haemophilia; 2013 Jan; 19(1):11-20. PubMed ID: 22913770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the clinical management of haemophilia.
    Bloom AL
    Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047
    [No Abstract]   [Full Text] [Related]  

  • 16. How to manage invasive procedures in children with haemophilia.
    Ljung RC; Knobe K
    Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
    Petrini P
    Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis in children with hemophilia: is it the optimal treatment?
    Lusher JM
    Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of mild haemophilia: a 30-year single centre experience.
    Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
    Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
    Astermark J; Morado M; Rocino A; van den Berg HM; von Depka M; Gringeri A; Mantovani L; Garrido RP; Schiavoni M; Villar A; Windyga J;
    Haemophilia; 2006 Jul; 12(4):363-71. PubMed ID: 16834735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.